CSTL EBITDA Margin
Castle Biosciences Inc · EBITDA Margin
CSTL EBITDA Margin
Latest reported-0.91%period ending
CSTL TTM EBITDA Margin (-16.51% → -0.91%)
TTM ebitda margin
High-resolution chart · PNG
CSTL ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -0.9057% | |
| -0.7405% | |
| 3.2952% | |
| 6.9866% | |
| 9.4063% | |
| 11.7502% | |
| 11.485% | |
| 8.041% | |
| 3.2536% | |
| -7.1253% | |
| -20.4852% | |
| -33.0328% | |
| -45.9922% | |
| -40.9285% | |
| -42.5747% | |
| -43.9074% | |
| -43.2952% | |
| -55.9415% | |
| -38.9052% | |
| -31.4448% | |
| -25.8852% | |
| -18.4675% | |
| -11.3234% | |
| 0.2353% | |
| 17.4931% | |
| 19.7415% | |
| 19.8168% | |
| 26.0419% | |
| 5.9706% | |
| -3.5725% | |
| -16.5083% |